SyntekaBio Inc (226330) — Financial Flexibility Index
SyntekaBio Inc (226330) has a Financial Flexibility Index of -0.09x as of September 2025. Free cash flow of ₩-1.98 Billion (operating CF ₩-2.01 Billion minus capex ₩30.01 Million) represents 0% of total liabilities (₩21.59 Billion). Check SyntekaBio Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SyntekaBio Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for SyntekaBio Inc across 8 annual periods. See SyntekaBio Inc (226330) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for SyntekaBio Inc (2017–2024)
Year-by-year free cash flow to debt coverage for SyntekaBio Inc. For the full company profile including market capitalisation, see 226330 market cap.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.25x | ₩-4.69 Billion | ₩-10.51 Billion | ₩18.77 Billion | ▼ -501.1% |
| 2023 | 0.06x | ₩1.35 Billion | ₩-8.08 Billion | ₩21.69 Billion | ▲ +514.1% |
| 2022 | 0.01x | ₩245.87 Million | ₩-8.51 Billion | ₩24.23 Billion | ▼ -71.6% |
| 2021 | 0.04x | ₩1.44 Billion | ₩-6.04 Billion | ₩40.25 Billion | ▲ +103.0% |
| 2020 | -1.20x | ₩-3.88 Billion | ₩-4.67 Billion | ₩3.24 Billion | ▲ +9.9% |
| 2019 | -1.33x | ₩-2.44 Billion | ₩-3.28 Billion | ₩1.84 Billion | ▼ -711.2% |
| 2018 | -0.16x | ₩-1.71 Billion | ₩-2.37 Billion | ₩10.47 Billion | ▲ +64.2% |
| 2017 | -0.46x | ₩-2.42 Billion | ₩-2.49 Billion | ₩5.29 Billion | — |